Last 46 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 27.51 | 46.13 | 25.57 | 13.76 | 14.32 | 73.49 | — | — | 4.74 | — | — | — | — | — | — | — | — | — | 3.12 | — | — |
| — | -37.2% | — | — | +202.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | -62.7% | — | — | |
| P/S Ratio | 9.66 | 11.09 | 84.00 | 18.69 | 8.52 | 4.61 | 8.93 | 10.77 | 12.20 | 46.73 | 28.96 | 48.69 | 32.66 | 138.40 | 35.45 | 113.65 | 64.72 | 25.51 | 1.75 | 74.45 | 106.46 |
| — | +140.4% | +840.2% | +73.5% | -30.1% | -90.1% | -69.1% | -77.9% | -62.6% | -66.2% | -18.3% | -57.2% | -49.5% | +442.6% | +1923.9% | +52.6% | -39.2% | -91.7% | -63.7% | -20.1% | -11.6% | |
| P/B Ratio | 6.95 | 4.84 | 4.63 | 6.48 | 4.84 | 3.47 | 3.80 | 3.66 | 2.76 | 3.38 | 2.39 | 1.53 | 1.97 | 2.11 | 1.70 | 1.57 | 1.89 | 2.27 | 1.78 | 2.51 | 3.29 |
| — | +39.5% | +21.7% | +77.1% | +75.5% | +2.6% | +58.8% | +139.7% | +40.3% | +60.1% | +40.8% | -3.0% | +4.3% | -6.8% | -4.3% | -37.3% | -42.7% | -59.6% | -71.2% | -54.0% | -40.9% | |
| P/FCF | 175.47 | 22.61 | — | — | 17.51 | 33.39 | — | — | 25.29 | — | — | — | — | — | — | — | — | — | 2.05 | — | — |
| — | -32.3% | — | — | -30.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | -74.6% | — | — | |
| EV / EBITDA | 38.48 | 347.37 | 43.16 | — | 23.15 | 12.27 | — | — | — | — | — | — | — | — | — | — | — | — | 1.31 | — | — |
| — | +2731.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -73.4% | — | — | |
| EV / EBIT | 48.53 | 18.42 | 14.42 | 10.64 | 9.80 | 13.62 | — | — | 3.27 | — | — | — | — | — | — | — | — | — | 1.31 | — | — |
| — | +35.3% | — | — | +199.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | -73.4% | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 94.3% | 92.7% | 100.0% | 90.6% | 95.0% | 96.6% | 90.1% | 88.6% | 100.0% | 99.9% | 98.6% | 97.0% | 97.6% | 87.6% | 98.1% | 93.6% | 95.9% | 98.2% | 99.9% | 96.8% | 95.8% |
| — | -4.0% | +11.0% | +2.2% | -5.0% | -3.3% | -8.7% | -8.6% | +2.4% | +13.9% | +0.5% | +3.7% | +1.8% | -10.7% | -1.8% | -3.3% | +0.2% | +17.3% | +0.0% | +3.1% | +4.7% | |
| Operating Margin | 21.8% | -3.9% | 152.4% | -14.2% | 35.1% | 37.3% | -83.2% | -217.3% | -178.3% | -470.1% | -1087.5% | -697.2% | -359.3% | -2327.2% | -417.9% | -969.4% | -484.9% | -66.5% | 84.5% | -355.9% | -340.1% |
| — | -110.5% | +283.1% | +93.5% | +119.7% | +107.9% | +92.3% | +68.8% | +50.4% | +79.8% | -160.2% | +28.1% | +25.9% | -3401.6% | -594.7% | -172.4% | -42.6% | +96.1% | -2.4% | +26.3% | +52.1% | |
| Net Margin | 60.8% | 36.2% | 426.2% | 150.3% | 52.5% | 14.9% | -45.5% | -239.6% | 282.7% | -576.8% | -1097.1% | -663.7% | -325.7% | -2245.5% | -402.2% | -926.4% | -475.1% | -73.4% | 83.0% | -471.9% | -248.3% |
| — | +143.7% | +1035.9% | +162.7% | -81.4% | +102.6% | +95.8% | +63.9% | +186.8% | +74.3% | -172.8% | +28.4% | +31.4% | -2960.0% | -584.4% | -96.3% | -91.3% | +96.3% | +1.0% | -144.1% | +68.8% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 34.1% | 4.1% | 5.8% | 14.0% | 7.8% | 2.8% | -4.8% | -18.7% | 17.5% | -10.0% | -20.7% | -5.1% | -4.8% | -8.2% | -4.7% | -3.1% | -3.4% | -1.6% | 23.5% | -3.9% | -2.3% |
| — | +44.9% | +221.0% | +175.1% | -55.6% | +128.3% | +77.0% | -266.0% | +464.7% | -22.1% | -339.6% | -61.9% | -41.5% | -408.4% | -120.0% | +19.0% | -50.6% | +81.5% | -35.3% | -38.0% | +74.6% | |
| ROA | 12.8% | 1.6% | 2.3% | 5.8% | 3.2% | 1.1% | -1.8% | -7.4% | 6.9% | -3.8% | -11.2% | -4.4% | -4.2% | -7.2% | -4.2% | -2.8% | -3.0% | -1.4% | 20.1% | -3.3% | -1.8% |
| — | +50.4% | +227.6% | +178.1% | -54.3% | +128.8% | +84.1% | -67.5% | +265.9% | +47.1% | -169.0% | -58.6% | -39.7% | -411.5% | -120.8% | +16.5% | -70.3% | +76.7% | -6.5% | -168.5% | +55.5% | |
| ROIC | 6.8% | -0.2% | 1.1% | -0.7% | 2.9% | 4.3% | -6.8% | -16.8% | -10.4% | -8.3% | -22.6% | -5.7% | -6.0% | -11.2% | -7.9% | -6.3% | -6.9% | -3.1% | 49.6% | -6.2% | -6.4% |
| — | -105.7% | +116.1% | +95.8% | +127.5% | +151.6% | +70.1% | -192.5% | -73.8% | +25.9% | -187.0% | +8.9% | +12.6% | -264.7% | -115.9% | -1.8% | -6.4% | +82.0% | -35.8% | +33.2% | +44.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.27 | 1.10 | 1.27 | 1.22 | 1.24 | 1.35 | 1.46 | 1.40 | 1.22 | 1.47 | 1.40 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -18.3% | -13.0% | -12.9% | +1.6% | -8.0% | +3.7% | — | +791669.5% | +244095.5% | +511838.7% | — | -84.4% | -53.7% | -83.0% | -73.6% | -64.1% | -99.5% | -99.3% | -99.7% | -99.7% | |
| Debt / EBITDA | 9.16 | 300.56 | 42.87 | — | 21.78 | 17.67 | — | — | — | — | — | — | — | — | — | — | — | — | 0.01 | — | — |
| — | +1600.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -99.2% | — | — | |
| Current Ratio | 3.37 | 3.59 | 3.37 | 3.91 | 4.88 | 5.54 | 5.15 | 7.52 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 | 4.47 | 8.98 | 14.70 | 10.36 | 11.36 | 7.48 | 11.50 | 13.88 |
| — | -35.2% | -34.7% | -48.0% | -44.0% | -41.4% | -40.7% | +125.4% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | -60.7% | +20.1% | +27.8% | -25.4% | +111.9% | +4.5% | +194.8% | +199.6% | |
| Quick Ratio | 3.37 | 3.59 | 3.37 | 3.91 | 4.88 | 5.54 | 5.15 | 7.64 | 8.71 | 9.45 | 8.68 | 3.34 | 5.42 | 4.47 | 8.98 | 14.70 | 10.36 | 11.36 | 7.48 | 11.50 | 13.88 |
| — | -35.2% | -34.7% | -48.8% | -44.0% | -41.4% | -40.7% | +128.7% | +60.7% | +111.7% | -3.3% | -77.3% | -47.7% | -60.7% | +20.1% | +27.8% | -25.4% | +111.9% | +4.5% | +194.8% | +199.6% | |
| Interest Coverage | 3.44 | 2.33 | 3.03 | 5.27 | 3.84 | 1.68 | -7.85 | -3.94 | 5.70 | -1.42 | -12.75 | — | — | — | — | — | — | — | — | — | -17.81 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying XOMA stock.
XOMA Royalty Corp.'s current P/E is 27.5x. The average P/E over the last 4 quarters is 24.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
XOMA Royalty Corp.'s current operating margin is 21.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking XOMA Royalty Corp.'s business trajectory between earnings reports.